Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease

Journal of Central South University (Medical Sciences)

Volumn 36, Issue 11, 2011, Pages 1090-1096

  Long, Haiyan ^a   Luo, Hong ^a   Chen, Ping ^a   Li, Yan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

C reactive protein; Chronic obstructive pulmonary disease; Interleukin 18; Lung function; Quality of life

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 18;

AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG; LUNG FUNCTION TEST; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; VITAL CAPACITY;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-18; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; VITAL CAPACITY;

EID: 84555196631     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2011.11.010     Document Type: Article

References (21)

1. Group of Chronic Obstructive Pulmonary Disease, Committee of Respiratory Disease, Chinese Medical Association. Guideline for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (2007 Revised Edition) [J]. Chinese Journal of Tuberculosis Respiratory Disease,2007, 30(1) :8-15.
2. Christ Crain M, Jaccard Stolz D.Bingisser R,et al. Effect of procalcitonin guided treatment on antibiotic use and outcome in lower respiratory tract infections; cluster randomised, single blinded intervention trial [J]. Lancet, 2004, 363(6): 600-607.
3. Pinto-Plata V M, Mullerova H, Toso J F, et al. C-restive protein in patients with COPD, control smokers and non-smokers [J].T horax, 2006, 61(4)::23-28. (Pubitemid 43106973)
4. Kitasato Y, Hoshino T, Kato S, et al. Enhanced expresssion of IL-18 and its receptor in patients with chronic obstructive pulmonary disease [J]. Proc Am Thorac Soc, 2006,3(2) :A629.
5. Weis N, Almdal T. C-reactive protein- can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease? [J]. Eur J Inter Med, 2006, 17 (2): 88-91. (Pubitemid 43265856)
6. de Torres J P, Cordoba-Lanus E, Lopez-Aguilar C, et al. Creactive protein levels and clinically important predictive outcomes in stable COPD patients[ J]. Eur Respir J, 2006, 27 (5) : 902-907. (Pubitemid 44911101)
7. Pinto-Plata V M, Mullerova H, Toso J F, et al. C-reactive protein in patients with COPD, control smokers and non-smokers [J]. Thorax, 2006, 6(1): 1-3.
8. Sugimoto T, Ishikawa Y, Yoshimoto T, et al. Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyper-responsiveness in a naive host mouse[J]. J Exp Med,2004,199 (4): 535-545. (Pubitemid 38233837)
9. Tsutsui H, Yoshimoto T, Hayashi N, et al. Induction of allergic. Inflammation by inter-leukin-18 in experimental animal models[J]. Immunol Rev, 2004, 202::115-138. (Pubitemid 39576909)
10. Hoshino T, Kato S, Oka N, et al. Pulmonary inflammation and emphysema Role of the cytokines IL-18 and IL-13 [J]. Am J Respir Crit Care Med, 2007, 76 (1) : 49-62. (Pubitemid 47048054)
11. Imaokal H, Hoshinol T, Takeii S, et al. Interleukin-18 production and pulmonary function in COPD [J]. Eur Respir J, 2008, 31:287-297.
12. Rovina N, Dima E, Gerassimou C, et al. Interleukin-18 in induced sputum; Association with lung function in chronic obstructive pulmonary disease [J]. Respir Med, 2009, 103 (7) : 1056-1062.
13. Kang M J, Homer R J, Gallo A, et al. IL-18 is induced and IL-18 receptor | alpha | plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation[J]. J Immunol, 2007, 178(3): 1948-1959. (Pubitemid 46154668)
14. Barnes PJ, Shapiro S D, Pauwels RA, et al. Chronic obstructive pulmonary disease molecular and cellular mechanisms[J]. Eur Respir J, 2003, 22 (4) : 672-688. (Pubitemid 37258549)
15. Chin C L, Manz L J, Lehman E E, el al. Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers[J]. Am J Respir Crit Care Med, 2005, 172 (3): 85-91. (Pubitemid 40923318)
16. Subodh V, Chao-H W, Shu H L, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis [J]. Circulation, 2002, 106 (10): 913.
17. Leorid S, Saquib S, Hartzel V S, et al. C-reactive protein relaxes human vessels in vitro [J]. Arterioscl Thromb Vase Biol, 2002, 22 (2): 1865-1868.
18. WU Shangjie, CHEN Ping, JIANG Xinian et al. C-reactive protein level and the correlation between lung function and CPR deveis in patients with chronic obstructive pulmonary disease [J]. Journal of Central South University. Medical Sciences, 2005,30 (4): 444446
19. Engstrom C P, Persson L O, Larsson S, et al . Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med,2002, 166(5): 680.
20. Fernanda M V, Boueri N D, Becki L, et al . Quality of life measured with a generic instrument (Short Form236) improves following pulmonary rehabilitation in patients with COPD [J]. Chest, 2001, 119(7): 72-84.
21. XU Ou, HAO Qinglin. Evaluating life quality of COPD patients with SGRQ[J]. Journal of Kunming Medical University, 2008 (3): 71-75.